Our Pricing

Wegovy Pill Dosage and Maintenance: The Complete Guide

Published on: June 03, 2026

Understanding the correct wegovy pill dosage guide UK protocols is essential for safe, effective weight management. At Cured Pharmacy, our UK-registered clinical team provides comprehensive dosing support for Wegovy® Oral Tablets (semaglutide pill), available from £79.00 with transparent pricing and free online consultation under three minutes.

How Wegovy Oral Tablets Differ from Injectable Semaglutide

Wegovy® Oral Tablets represent a significant advancement in weight management treatment, offering the same active ingredient—semaglutide—as the injectable formulation, but in a convenient once-daily tablet form. The oral formulation uses SNAC (sodium N-[8-(2-hydroxybenzoyl) amino] caprylate) technology to enhance absorption across the stomach lining, overcoming the traditional challenge of delivering peptide medications orally [1].

Unlike the injectable version administered once weekly, oral semaglutide requires daily dosing on an empty stomach with minimal water (up to 120ml). Patients must wait 30 minutes before eating, drinking, or taking other medications to ensure optimal absorption [1]. This different administration profile means the dosing schedule and titration protocol vary considerably from injectable Wegovy.

Clinical trials demonstrated that oral semaglutide achieved significant weight reduction when combined with lifestyle modifications, with patients experiencing an average 15.1% body weight reduction over 68 weeks in the STEP 1 oral trial [2]. The oral formulation offers an alternative for patients who prefer not to self-inject or have needle phobia, whilst maintaining the GLP-1 receptor agonist mechanism that reduces appetite and improves glycaemic control.

Wegovy Pill Dosage Titration Schedule

The Wegovy oral tablet dosing protocol follows a carefully structured titration schedule designed to minimise gastrointestinal side effects whilst building therapeutic efficacy. Your UK prescriber will determine your specific starting dose based on your medical history, current medications, and weight management goals, but the standard MHRA-approved schedule begins at a low dose and gradually increases over several months.

The typical titration schedule starts with 3mg once daily for four weeks, allowing your body to adjust to the GLP-1 receptor agonist effects. This is followed by 7mg daily for weeks 5-8, then 14mg daily for weeks 9-12. Most patients continue escalating to 25mg daily for weeks 13-16, with the final maintenance dose of 50mg once daily beginning from week 17 onwards [1]. Each dose increase occurs at four-week intervals, providing adequate time for tolerance development and side effect assessment.

It's crucial never to skip titration steps or accelerate the schedule without explicit guidance from your UK prescriber. Rushing the dose escalation significantly increases the risk of nausea, vomiting, diarrhoea, and other gastrointestinal adverse effects that may lead to treatment discontinuation [3]. If you experience persistent side effects at any dose level, your prescriber may extend that dose phase for an additional four weeks before progressing, or in some cases, reduce to the previous tolerated dose.

What If I Miss a Dose?

If you miss a dose of Wegovy oral tablets, take it as soon as you remember on the same day, provided you can still follow the 30-minute fasting requirement before your first meal. If you've already eaten or it's late in the day, skip the missed dose and resume your normal schedule the following morning. Never take two doses in one day to compensate for a missed tablet, as this increases the risk of severe gastrointestinal side effects and does not improve efficacy [1]. Consistent daily dosing at the same time each morning optimises absorption and helps establish a reliable routine.

Maintenance Dose: Long-Term Wegovy Pill Management

Once you reach the 50mg maintenance dose—typically from week 17 onwards—this becomes your standard daily dose for continued weight management. Clinical evidence shows that maintaining this dose, combined with lifestyle modifications including reduced-calorie diet and increased physical activity, supports sustained weight loss over extended periods [2]. The maintenance phase is not a fixed duration; many patients continue treatment for 12 months or longer under ongoing prescriber supervision.

During maintenance therapy, you'll have regular clinical reviews with your UK prescriber to assess treatment response, monitor for adverse effects, and evaluate whether continued therapy remains appropriate. NICE guidance suggests reviewing weight loss progress at 6-12 months, with treatment continuation justified if you've achieved at least 5% body weight reduction and demonstrate commitment to lifestyle changes [4]. Some patients may require dose adjustment during maintenance if side effects emerge or if weight loss plateaus significantly.

It's important to understand that Wegovy oral tablets work most effectively as part of a comprehensive weight management programme, not as a standalone solution. Your prescriber will discuss realistic expectations: whilst clinical trials showed average weight reductions exceeding 15%, individual results vary considerably based on adherence, baseline BMI, dietary changes, and physical activity levels [2]. Continuous treatment is typically required to maintain weight loss, as discontinuation often results in gradual weight regain.

When to Contact Your Prescriber

Contact your UK prescriber immediately if you experience severe abdominal pain that doesn't resolve, persistent vomiting preventing fluid intake, signs of pancreatitis (severe upper abdominal pain radiating to the back), symptoms of gallbladder disease, or rapid heart rate at rest. These may indicate serious adverse effects requiring urgent clinical assessment [3]. Also reach out if you're consistently unable to tolerate your current dose despite following administration instructions correctly, or if you've experienced minimal weight loss (less than 3% body weight) after six months at the maintenance dose.

Wegovy Pill Dosage vs Injection: Key Differences

Whilst both formulations contain semaglutide and work through the same GLP-1 receptor agonist mechanism, the dosing protocols differ substantially. Injectable Wegovy uses a once-weekly subcutaneous injection, starting at 0.25mg weekly and titrating over 16-20 weeks to a maintenance dose of 2.4mg weekly [1]. The oral formulation requires daily administration with strict timing requirements, reaching a 50mg daily maintenance dose—a much higher nominal dose due to the lower bioavailability of oral absorption compared to subcutaneous injection.

The titration period for oral tablets extends over approximately 16 weeks with five dose escalations, similar in duration to the injectable schedule but with more frequent dose adjustments. Patients on oral semaglutide must adhere to the 30-minute fasting window before and after administration, whilst injectable users have no such timing restrictions [1]. This makes the oral formulation less convenient for some patients despite eliminating injection-related concerns.

Clinical trial data suggests comparable efficacy between formulations when patients adhere to prescribed protocols, though direct head-to-head trials are limited. The choice between oral and injectable Wegovy typically depends on patient preference regarding needles versus daily dosing requirements, lifestyle factors affecting morning routine consistency, and individual tolerance profiles [2]. Your UK prescriber at Cured Pharmacy can discuss which formulation best suits your circumstances during your clinical assessment.

Managing Side Effects During Dose Escalation

Gastrointestinal side effects—particularly nausea, diarrhoea, constipation, and abdominal discomfort—are the most commonly reported adverse effects during Wegovy oral tablet titration, typically peaking within the first few days after each dose increase [3]. These effects usually diminish over 1-2 weeks as your body adjusts to the higher dose. Eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking the tablet at a consistent time each morning can help minimise these symptoms.

If nausea becomes problematic, try ginger tea, eating bland foods like crackers or toast, and avoiding strong food odours. For constipation, increase dietary fibre gradually, maintain adequate fluid intake, and consider discussing a gentle laxative with your prescriber if symptoms persist beyond a few days [3]. Diarrhoea usually resolves spontaneously but requires attention to hydration and electrolyte balance; contact your prescriber if it's severe or accompanied by signs of dehydration.

Less common but more serious side effects include acute pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from vomiting/diarrhoea), and hypoglycaemia in patients taking concomitant diabetes medications [3]. Your UK prescriber will review your full medication list and medical history before prescribing to identify any contraindications or necessary dose adjustments to other treatments. Never discontinue Wegovy abruptly without consulting your prescriber, particularly if you're also taking diabetes medications that may require concurrent adjustment.

Optimising Absorption and Efficacy

To maximise oral semaglutide absorption, take your tablet first thing in the morning on an empty stomach with no more than 120ml (approximately half a cup) of plain water. Swallow the tablet whole without crushing, chewing, or splitting it. Set a timer for 30 minutes and avoid all food, beverages (including coffee, tea, or additional water), and other oral medications during this period [1]. After 30 minutes, you can eat breakfast and take other medications as normal. Consistency in this routine significantly impacts treatment efficacy and reduces dose-to-dose variability in absorption.

Wegovy Pill Pricing and Access at Cured Pharmacy

Wegovy® Oral Tablets are available at Cured Pharmacy from £20 off first order using code WEIGHTLOSSNEW

All weight loss medications at Cured Pharmacy require a clinical assessment by a UK prescriber, conducted through our secure online consultation platform that takes under three minutes to complete. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), leads a team of experienced clinicians who review every consultation to ensure treatments are clinically appropriate, safe given your medical history, and compatible with your current medications. If oral semaglutide isn't suitable for you, our prescribers may recommend alternative treatments such as injectable Wegovy, Mounjaro, Saxenda, or orlistat-based options depending on your individual circumstances.

We're a fully regulated UK pharmacy (GPhC Registration Number 9012511) dispensing only genuine, UK-licensed medications sourced through authorised wholesalers. Every prescription is fulfilled to MHRA standards with 100% discreet packaging, and our clinical team remains available for ongoing support throughout your treatment journey. If you have questions about dosing, side effects, or treatment suitability at any point, you can contact our pharmacy team on (+44) 116 4646009 during business hours for professional guidance.

Scientific References

1. Novo Nordisk. (2024). Wegovy (semaglutide) oral tablets: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/ [accessed 13 August 2026]
2. Knop, F. K., et al. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 402(10403), 705-719. https://doi.org/10.1016/S0140-6736(23)01185-6 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2024). Semaglutide (Wegovy): guidance for healthcare professionals on managing side effects. GOV.UK. https://www.gov.uk/drug-safety-update [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, lifestyle modifications, and individual patient factors.